AMANDA STONE: Open Payments
NPI 1821338252 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,131 in 124 payments from 23 companies in 2025. Trend: 2023 $1,505 · 2024 $2,481 · 2025 $2,131
Food & beverage: $2,131
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $353 |
| ABBVIE INC. | 25 | $306 |
| AstraZeneca Pharmaceuticals LP | 11 | $211 |
| Lilly USA, LLC | 9 | $169 |
| GlaxoSmithKline, LLC. | 9 | $159 |
| PFIZER INC. | 6 | $121 |
| Axsome Therapeutics, Inc. | 5 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $92 |
| Corcept Therapeutics | 4 | $83 |
| Phathom Pharmaceuticals, Inc. | 9 | $66 |
Products named: Wegovy, JARDIANCE, FARXIGA, TRELEGY ELLIPTA, Ozempic, VRAYLAR, MOUNJARO, QULIPTA.
Industry payments across NC — which companies pay providers there.
